| Code | 4157E | ||||||||||
| MA number | 44/0166/23-S | ||||||||||
| Product Form: | cps dur 30x500 mg (blis.PVC/Aclar/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | MAKPHARM d.o.o., Croatia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 31.07.2023 |
| Validity: | 31.07.2028 |
| SPC: |
SPC_XYBAID 500 mg tvrdé kapsuly_06.2024.pdf
|
| PIL: |
PIL_XYBAID 500 mg tvrdé kapsuly_06.2024.pdf
|
| Safety feature | Yes |
| Data update: | 13.06.2024 |
